|SLA AX -- Australia Stock|| |
0.039 0.00 0.00%
Head of Medical Development - RussiaWe currently do not have informatin regarding Vladimir Trusov. This executive tanure with SLA AX is not currenlty determined.
61 3 9820 2699 http://www.solagran.com
The company has return on total asset (ROA)
of (21.17) %
which means that it has lost $21.17 on every $100 spent on asset. This is way below average.
The company has accumulated 7.26 M in total debt with debt to equity ratio (D/E) of 0.39 which is about average as compared to similar companies. SLA AX has Current Ratio of 1.18 suggesting that it may have difficulties to pay its financial obligations in time and when they become due.
Solagran Limited, a biotechnology company, engages in the research and commercial development of Bioeffectives, as well as patent protection for the extraction and application of Bioeffectives. SLA AX (SLA) is traded on Australian Securities Exchange in Australia. It is located in Melbourne, VIC and employs 10 people.